Faculty

Sascha Dublin

Affiliate Professor, Epidemiology

206-287-2870

Education

PhD Epidemiology, University of Washington, 1999
MD University of Washington, 2001

Contact

206-287-2870

Kaiser Permanente Washington Health Research Institute
1730 Minor Avenue, Suite 1600
Seattle, WA 98101

Research Interests

Dr. Dublin’s research interests include pharmacoepidemiology, pregnancy outcomes and perinatal epidemiology; aging; and cardiovascular epidemiology. Her work uses real-world health care data from Group Health and many other sources to better understand the safety and effectiveness of medications and other medical interventions.  She often focuses on the impact of interventions in vulnerable populations, particularly pregnant women and older adults. She also has interest and expertise in using novel statistical and epidemiologic methods to answer real-world questions, such as the use of two-phase study designs to reduce bias and Natural Language Processing  to extract information from electronic medical records (EMRs).  She is the Group Health site Principal Investigator for the Medication Exposures in Pregnancy Risk Evaluation Program (MEPREP), a multisite collaboration that has developed data sets including 1.2 million pregnancies across 11 health plans to examine medication safety in pregnant women.

Recent Publications (PubMed)

How do falls-risk increasing drugs modify the association between index falls and future falls and fracture burden? Secondary data analysis from the Irish longitudinal study on ageing.
(2026 Jul 28)
Eur Geriatr Med
Cloney T, Kenny RA, Briggs R

Environment-dependent benefits of sociality in Soay sheep.
(2026 Jul 1)
Proc Biol Sci 293(2075):
Siracusa ER, Bal X, De Moor D, Albery GF, Beattie R, Ravindran S, Wiersma E, Renwick Wilson A, Pemberton JM, Nussey DH, Silk MJ

Do psychological interventions in childhood and adolescence prevent later mental illness? A commentary on Vassard et al. (2026).
(2026 Jul 28)
J Child Psychol Psychiatry
Kelleher I

'Optimising Survivorship Care in Hodgkin's Lymphoma: Aligning Practice with Ireland's AYA Cancer Framework'.
(2026 Jul 28)
J Cancer Policy
Kearney M, Faithfull S, Leech M

Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study.
(2026 Jul 28)
Lancet
McLaughlin VV, Solum D, Lachant D, Ataya A, Barberà JA, Meyer GB, Chang SA, Channick R, Church C, Feenstra J, Gaine S, Giannakoulas G, Jerjes-Sanchez C, Khanna D, Kim NH, Oudiz R, Preston IR, Sood N, Torres F, Vachiery JL, Pulido T, Cella D, Deng C, Escudero M, Lacasse V, Peterson L, Benza R, Humbert M, ADVANCE OUTCOMES Investigators

Show complete publication list

In the News